| Andresen EL, Wilson KA, Castillo A, et al.
Patient motivation for participating in clinical trials for depression: validation of the motivation for clinical trials inventory-depression. [JOURNAL ARTICLE]
Int Clin Psychopharmacol 2009 Nov 6.
Abstract | Full Citation | Find Related Articles | | Papakostas GI, Clain A, Ameral VE, et al.
Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study. [JOURNAL ARTICLE]
Int Clin Psychopharmacol 2009 Nov 5.
Abstract | Full Citation | | Trifirò G, Sini G, Sturkenboom MC, et al.
Prescribing pattern of antipsychotic drugs in the Italian general population 2000-2005: a focus on elderly with dementia. [JOURNAL ARTICLE]
Int Clin Psychopharmacol 2009 Nov 5.
Abstract | Full Citation | | Frauger E, Pauly V, Thirion X, et al.
Estimation of clonazepam abuse liability: a new method using a reimbursed drug database. [JOURNAL ARTICLE]
Int Clin Psychopharmacol 2009 Oct 8.
Abstract | Full Citation | | Swadi HS, Craig BJ, Pirwani NZ, et al.
A trial of quetiapine compared with risperidone in the treatment of first onset psychosis among 15- to 18-year-old adolescents. [JOURNAL ARTICLE]
Int Clin Psychopharmacol 2009 Oct 5.
Abstract | Full Citation | | Brambilla F, Samek L, Company M, et al.
Multivariate therapeutic approach to binge-eating disorder: combined nutritional, psychological and pharmacological treatment. [JOURNAL ARTICLE]
Int Clin Psychopharmacol 2009 Sep 29.
Abstract | Full Citation | | Montgomery SA, Fava M, Padmanabhan SK, et al.
Discontinuation symptoms and taper/poststudy-emergent adverse events with desvenlafaxine treatment for major depressive disorder. [JOURNAL ARTICLE]
Int Clin Psychopharmacol 2009 Sep 23.
Abstract | Full Citation | | Schosser A, Kasper S
The role of pharmacogenetics in the treatment of depression and anxiety disorders. [JOURNAL ARTICLE]
Int Clin Psychopharmacol 2009 Sep 4.
Abstract | Full Citation | | Dougherty DD, Jameson M, Deckersbach T, et al.
Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder. [JOURNAL ARTICLE]
Int Clin Psychopharmacol 2009 Aug 28.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Wyrwich K, Harnam N, Revicki DA, et al.
Assessing health-related quality of life in generalized anxiety disorder using the Quality Of Life Enjoyment and Satisfaction Questionnaire. [JOURNAL ARTICLE]
Int Clin Psychopharmacol 2009 Aug 22.
Abstract | Full Citation |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
